Section 21 Access to Unregistered Medicines – IVERMECTIN CONTROLLED COMPASSIONATE USE PROGRAMME

Section 21 Access to Unregistered Medicines – IVERMECTIN CONTROLLED COMPASSIONATE USE PROGRAMME

Given that there is currently no credible evidence to support a therapeutic role for Ivermectin in COVID-19, SAHPRA has decided to terminate the Programme with immediate effect.

Archive

Ivermectin Controlled Compassionate Use Programme

Date uploaded

2022 May

Download latest version
File Type: www
Category: Communication to industry, Guideline
Unit: Emergency use, Section 21, Unregistered products